Daiwa Securities Group Inc. Pacira Bio Sciences, Inc. Transaction History
Daiwa Securities Group Inc.
- $22.4 Billion
- Q4 2024
A detailed history of Daiwa Securities Group Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 169 shares of PCRX stock, worth $4,394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169
Previous 169
-0.0%
Holding current value
$4,394
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.5MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$208 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$137 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$84.8 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$51.8 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.19B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...